CN102861310A - Medicine for hepatitis B - Google Patents
Medicine for hepatitis B Download PDFInfo
- Publication number
- CN102861310A CN102861310A CN2012103624012A CN201210362401A CN102861310A CN 102861310 A CN102861310 A CN 102861310A CN 2012103624012 A CN2012103624012 A CN 2012103624012A CN 201210362401 A CN201210362401 A CN 201210362401A CN 102861310 A CN102861310 A CN 102861310A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- hepatitis
- herba
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 229940079593 drug Drugs 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000010231 banlangen Substances 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- 239000000919 ceramic Substances 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 2
- 241001522129 Pinellia Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 241001530126 Scrophularia Species 0.000 claims description 2
- 241000207929 Scutellaria Species 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 229940097275 indigo Drugs 0.000 claims description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000002893 slag Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 241000700721 Hepatitis B virus Species 0.000 abstract description 5
- 239000009636 Huang Qi Substances 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241001529821 Agastache Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000184734 Pyrus japonica Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 241000304432 Sedum sarmentosum Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 6
- 230000003908 liver function Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 101710132601 Capsid protein Proteins 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001543 purgative effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 244000101724 Apium graveolens Dulce Group Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A hepatitis B is caused by infecting the hepatitis B virus due to the fact the healthy atmosphere in the human body is insufficient. The invention relates to a traditional Chinese medicine preparation for treating the hepatitis B, which comprises the raw materials in part by weight: 3 parts of radix adenophorae, 3 parts of radix rehmanniae, 2 parts of radix ophiopogonis, 2 parts of angelica sinensis, 2 parts of fructus lycii, 2 parts of melia toosendan, 3 parts of codonopsis pilosula, 3 parts of radix astragali, 3 parts of polygonum cuspidatum, 3 parts of radix isatidis, 1 part of indigo naturalis, 3 parts of radix bupleuri, 2 parts of poria cocos, 2 parts of rhizoma atractylodis macrocephalae, 2 parts of radix glycyrrhizae preparata, 2 parts of rhizoma pinelliae, 1.5 parts of rhizoma zingiberis recens, 2 parts of pericarpium citri reticulatae, 2 parts of radix aucklandiae, 1 part of ramulus cinnamomi, 2 parts of radix puerariae, 2 parts of agastache rugosus, 3 parts of prepared common monkshood daughter root, 2 parts of herba epimedii, 1.5 parts of semen cuscutae, 1.5 parts of herba cynomorii, 3 parts of radix scrophulariae, 3 parts of tortoise plastron, 3 parts of herba hyperici japonica, 3 parts of sedum sarmentosum, 2 parts of radix scutellariae, 2 parts of fructus aurantii and 2 parts of fructus schisandrae. The traditional Chinese medicine preparation for treating the hepatitis B is obtained by decocting the raw materials by water, filtrating the dregs and mixing with indigo naturalis. The invention has the effects of strengthening healthy atmosphere in the human body and inhibiting or killing the hepatitis B virus, and has the functions of strengthening the body resistance, eliminating evil and detoxifying. The traditional Chinese medicine preparation has an excellent efficacy on treating the hepatitis B. If the patients can persist in completely treatment, the healing aim can be achieved.
Description
Technical field is a kind of Chinese medicine preparation for the treatment of hepatitis B.
The background technology hepatitis B, the modern medicine name is that a kind of infection due to the hepatitis B virus is sick.The virus of hepatitis B is the pathogen of hepatitis B.Found at present to have 3 kinds of antigens in the infection course of hepatitis B virus at least.
1, hbs antigen (HBsAg), can induce body produce corresponding antibody (anti--HBs).
2, hepatitis B core antigen (HBsAg) is present in the nucleus, can't check free (HBcAg) in the blood circulation, its corresponding antibodies (anti--HBc).
3, hepatitis B e antigen (HBeAg), can be used as has hepatitis B to copy with serum to have a communicable important indicator in the body, its corresponding antibodies (anti--HBe)
The people is to the equal susceptible of hepatitis B virus, and in Susceptible population, (positive QI-insufficiency) infects easily when the Immune Dysfunction premunition weakens.From traditional Chinese medical science organic conception, " interior warp " has argument and the rule for the treatment of of " healthy energy deposit in, heresy can not done ", " institute of heresy gathers, and its gas must be empty, treatment of deficiency-syndrome by reinforcement, treating excess syndrome with purgative methods, diseases with invaded pathogens should be treated by expelling ".
Summary of the invention is according to the argument of " interior warp " " institute of heresy gathers, its gas must void ": when hepatitis B (hereinafter to be referred as hepatitis B) is exactly positive QI-insufficiency (immunologic hypofunction) due to the hepatitis b virus infection." pathological change of vital QI being weakened and pathogen being violent " and a series of somatization symptom thereof appear: such as symptoms such as inappetence, weak, vomiting, abdominal distention, diarrhoea, pain in the hepatic region, low grade fever, yellow urine; Ordinary circumstance is relatively poor, and complexion is dark and pitch-dark, and spider angioma or liver palm can be arranged, hepatomegaly and matter is harder.But spleen is enlargement also; It is outward the symptom of damage that the livers such as arthritis, urticaria, nephritis, ulcerative colitis, chronic gastritis can appear in part patient; More serum glutamic pyruvic transminase continues or repeatedly raises, often long-term obvious unusual with flocculation-turbidity test, can have albumin to lower, and globulin increases, and IgG Chang Mingxian increases, and also visible hyporrhea is inclined to, such as gingiva bleeding gingival hemorrhage and purpura.Develop at last liver cirrhosis, hepatocarcinoma.
The Chinese medicine preparation that the present invention treats hepatitis B is according to " interior warp " " in healthy energy deposits; heresy can not be done ", " institute of heresy gathers; its gas must be empty ", the argument of " treatment of deficiency-syndrome by reinforcement; treating excess syndrome with purgative methods; diseases with invaded pathogens should be treated by expelling " or " seeing the disease of liver; tonifying the spleen in the ban " and the rule for the treatment of are carried out compatibility, its raw material by 2 parts of: 2 parts of Fructus Schisandrae Chinensis of 3 parts of Radix Rehmanniae of Radix Adenophorae (Radix Glehniae), 2 parts of Fructus Aurantiis of 3 parts of Radix Scutellariaes of 3 portions of Herba Sedis of 3 parts of Herba Hyperici Japonici of 3 parts of Carapax et Plastrum Testudiniss of 1.5 portions of Radix Scrophulariaes of 1.5 parts of Herba Cynomoriis of 2 parts of Semen Cuscutae of 3 parts of Herba Epimedii of 2 parts of Radix Aconiti Lateralis Preparatas of 2 portions of Herba Pogostemoniss of 1 part of Radix Puerariae of 2 parts of Ramulus Cinnamomi of 2 parts of Radix Aucklandiae of 1.5 parts of Pericarpium Citri Reticulataes of 2 portions of Rhizoma Zingiberis Recenss of 2 parts of Rhizoma Pinelliaes of 2 parts of Radix Glycyrrhizae Preparatas of 2 parts of Rhizoma Atractylodis Macrocephalaes of 3 parts of Poria of 1 part of Radix Bupleuri of 3 parts of Indigo Naturaliss of 3 parts of Radix Isatidis of 3 parts of Rhizoma Polygoni Cuspidati of 3 parts of Radixs Astragali of 2 parts of Radix Codonopsis of 2 parts of Fructus Toosendans of 2 portions of Fructus Lyciis of 2 parts of Radix Angelicae Sinensis, 3 parts of Radix Ophiopogonis by weight forming, decocting and get final product.
Wherein the Radix Rehmanniae, Radix Adenophorae (Radix Glehniae), Radix Ophiopogonis, Radix Angelicae Sinensis, Fructus Lycii, Fructus Schisandrae Chinensis, nourishing YIN and benefiting blood promote the production of body fluid with easing the affected liver, Fructus Toosendan, Radix Bupleuri, catharsis irritability; Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Glycyrrhizae Preparata, Pericarpium Citri Reticulatae, the Rhizoma Pinelliae, wash drink in the Ramulus Cinnamomi invigorating YANG fill temperature, Fructus Aurantii is with the loose gastrointestinal stagnation of QI, Herba Pogostemonis, the Radix Aucklandiae, the Radix Puerariae eliminating turbid pathogen with aromatics, with the yang invigorating circulation of qi promoting, regard it as in the Rhizoma Zingiberis Recens appetizing accent, Rhizoma Polygoni Cuspidati, Radix Isatidis, Indigo Naturalis, heat-clearing and toxic substances removing, the effect while Fructus Schisandrae Chinensis that inhibition or kill virus may be arranged, the Radix Astragali, Radix Bupleuri, Herba Sedi, Herba Hyperici Japonici energy transaminase lowering, Radix Glycyrrhizae Preparata, Radix Angelicae Sinensis, Radix Bupleuri, Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Fructus Schisandrae Chinensis can also the liver protecting, prevent that liver glycogen from reducing prevention fat and accumulating in liver, suppress fibroplasia, strengthen the phagocytic function of RE system, improve resistance against diseases, promote hepatocyte newborn; Radix Aconiti Lateralis Preparata, Herba Epimedii, Semen Cuscutae, Herba Cynomorii, the Radix Rehmanniae, Radix Ophiopogonis, Radix Scrophulariae, Carapax et Plastrum Testudinis, Radix Glycyrrhizae Preparata promote internal antibody to catch front generation.
Up to the present hepatitis B does not also have specific drug, most of hepatitis B patients, and HBsAg still is difficult to turn out cloudy rapidly after treatment, thus easily easily transformation of delay of the course of disease, hepatitis B---liver cirrhosis---hepatocarcinoma.And treat hepatitis B with medicine for treating hepatitis B of the present invention, and liver function recovery is normal at short notice to make the patient, and HBsAg turns out cloudy rapidly, and HBV-DNA was down in normal range.Stop hepatitis B to change, finally make hepatitis B patient recovery from illness.
In sum, by the medicine for treating hepatitis B that the above-mentioned raw materials compatibility of drugs forms, have nourishing YIN and dispersing the stagnated liver-QI, invigorating the spleen and regulating the stomach, regulating QI to relieve pain, QI invigorating detoxifcation, facilitate antibody to generate liver-protective effect.
The treatment hepatitis B that Chinese medicine preparation energy of the present invention is effective and the somatization symptom that occurs together thereof.The for many years clinical experiment by countless patients are carried out, its result has all obtained significant curative effect.Now with the situation of the relevant clinical treatment of 100 routine patients, details are as follows:
1. patient profile: select the projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: the out-patient.
3. patient enters the group standard: without exception so that national hospital laboratory examination result---hepatitis B is as standard; Sex, age are not limit, the various Chinese and western drugses of stopping using before the treatment.
4. method of administration: decoction being taken warmly, every day 3 times, service once 1 hour early, middle and late ante cibum, and 3 months was 1 course for the treatment of.
5. efficacy evaluation:
(1) recovery from illness: laboratory examination (liver function, 2 pairs half.HBV-DNA) fully normal, the somatization symptom complete obiteration.
(2) produce effects: laboratory examination (liver function, 2 pairs half.HBV-DNA) approach normally, somatization symptom significantly alleviates.
(3) effective: laboratory examination (liver function, 2 pairs half.HBV-DNA) take a turn for the better to some extent, somatization symptom alleviates to some extent.
(4) invalid: laboratory examination (liver function, 2 pairs half.HBV-DNA) do not take a turn for the better, somatization symptom does not alleviate.
6. efficacy analysis;
(1) sex: be pressed into the group standard, 100 examples wherein: male's 40 examples (40%); Women's 60 examples (60%).
(2) course of disease: 70 examples of 30 examples more than 1 year in 5 months-1 year.
(3) age group: 8-17 year 20 examples, 18-40 year 60 examples, 20 examples more than 40.
(4) curative effect: effective percentage 100%, recovery from illness are more than 95%, and wherein 4% patient does not adhere to taking medicine and not recovery from illness
Received remarkable curative effect by adopting Chinese medicine preparation treatment hepatitis B of the present invention.Before this group case treatment, most of patients all pass through Chinese and western medical and is treated all because unsatisfactory curative effect or the state of an illness worsen more, and come to cure.
In taking Chinese medicine preparation process of the present invention, must not take other medicines.
Chinese medicine preparation nourishing YIN and dispersing the stagnated liver-QI of the present invention, invigorating the spleen and regulating the stomach, regulating QI to relieve pain, QI invigorating detoxify, facilitate antibody to generate liver-protective effect.The patient takes rear without any toxicity, and evident in efficacy.It is cured effect and reaches more than 95%
Case: (1) patient: the Zhang Jianming man lived the peaceful township of Changshou District thunder man ditch in 27 years old.On March 11st, 1998, come the here diagnosis and treatment, be diagnosed as hepatitis B through doctor trained in Western medicine chemical examination, through treat with Chinese medicine preparation of the present invention take medicine to April 1 patient go long-lived institute of traditional Chinese medicine laboratory examination liver function, 2 pairs half.HBV-DNA is all normal.
(2) patient: it is curved that Yang Xiao celery woman lived the yellow angle of Changshou District in 30 years old.On July 24th, 2004, come the here diagnosis and treatment, through doctor trained in Western medicine inspection diagnosis 1, hepatitis B, 2, stomach and duodenal bulbar ulcer, 3, cardia be scorching, 4, chronic superficial gastritis.5, infertile through, fully recovering through gastroscopy stomach and all pathological changes of duodenum after 3 months with Chinese medicine preparation treatment of the present invention, the rear hepatitis B that continues to take medicine also heals, and gives birth to a girl.
7. the specific embodiment is with the raw material medicine: Radix Adenophorae (Radix Glehniae) 30g Radix Rehmanniae 30g 20g Radix Ophiopogonis Radix Angelicae Sinensis 20g Fructus Lycii 20g Fructus Toosendan 20g Radix Codonopsis 30g Radix Astragali 30g Rhizoma Polygoni Cuspidati 30g Radix Isatidis 30g Indigo Naturalis 10g Radix Bupleuri 30g Poria 20g Rhizoma Atractylodis Macrocephalae 20g Radix Glycyrrhizae Preparata 20g Rhizoma Pinelliae 20g Rhizoma Zingiberis Recens 15g Pericarpium Citri Reticulatae 20g Radix Aucklandiae 20g Ramulus Cinnamomi 10g Radix Puerariae 20g Herba Pogostemonis 20g Radix Aconiti Lateralis Preparata 30g Herba Epimedii 20g Semen Cuscutae 15g Herba Cynomorii 15g Radix Scrophulariae 30g Carapax et Plastrum Testudinis 30g Herba Hyperici Japonici 30g Herba Sedi 30g Radix Scutellariae 20g Fructus Aurantii 20g Fructus Schisandrae Chinensis 20g is except Indigo Naturalis, first with Radix Aconiti Lateralis Preparata, Carapax et Plastrum Testudinis is put into ceramic pot, add an amount of water, add a cover, after being fried boiling with high heat first, change slow fire into, after remaining medicinal cold water covers the Radix Aconiti Lateralis Preparatas such as powder immersion and was decocted first 1 hour, medicine and the water of bubble are poured in the ceramic pot with Radix Aconiti Lateralis Preparata with frying in shallow oil, change into after being fried boiling and pour out medicinal liquid half an hour at a simmer, adding cold water enters in the ceramic pot again, decoction is the same, and 2 times medicinal liquid hybrid filtering is called in Indigo Naturalis.Oral altogether, took in 2 days, every day 3 times, service once 1 hour early, middle and late ante cibum.
Claims (2)
1. Chinese medicine preparation for the treatment of hepatitis B, its feature: be that crude drug forms the above-mentioned raw materials medicine except Indigo Naturalis by weight by 2 parts of 2 parts of Fructus Schisandrae Chinensis of 3 parts of Radix Rehmanniae of Radix Adenophorae (Radix Glehniae), 2 parts of Fructus Aurantiis of 3 parts of Radix Scutellariaes of 3 portions of Herba Sedis of 3 parts of Herba Hyperici Japonici of 3 parts of Carapax et Plastrum Testudiniss of 1.5 portions of Radix Scrophulariaes of 1.5 parts of Herba Cynomoriis of 2 parts of Semen Cuscutae of 3 parts of Herba Epimedii of 2 parts of Radix Aconiti Lateralis Preparatas of 2 portions of Herba Pogostemoniss of 1 part of Radix Puerariae of 2 parts of Ramulus Cinnamomi of 2 parts of Radix Aucklandiae of 1.5 parts of Pericarpium Citri Reticulataes of 2 portions of Rhizoma Zingiberis Recenss of 2 parts of Rhizoma Pinelliaes of 2 parts of Radix Glycyrrhizae Preparatas of 2 parts of Rhizoma Atractylodis Macrocephalaes of 3 parts of Poria of 1 part of Radix Bupleuri of 3 parts of Indigo Naturaliss of 3 parts of Radix Isatidis of 3 parts of Rhizoma Polygoni Cuspidati of 3 parts of Radixs Astragali of 2 parts of Radix Codonopsis of 2 parts of Fructus Toosendans of 2 portions of Fructus Lyciis of 2 parts of Radix Angelicae Sinensis, 3 parts of Radix Ophiopogonis, decocting, remove slag and get liquid and filter and to call in Indigo Naturalis, and get final product.
2. a kind of Chinese medicine preparation for the treatment of hepatitis B according to claim 1 is characterized in that: first Radix Aconiti Lateralis Preparata, Carapax et Plastrum Testudinis are put into ceramic pot, add an amount of water, add a cover, after being fried boiling with high heat first, change slow fire into, after remaining medicinal cold water covers the Radix Aconiti Lateralis Preparata such as powder immersion and was decocted first 1 hour, medicine and the water of bubble are poured in the ceramic pot with Radix Aconiti Lateralis Preparata with frying in shallow oil, change into after being fried boiling and pour out medicinal liquid half an hour at a simmer, add cold water again and enter in the ceramic pot, decoction is the same, 2 times medicinal liquid hybrid filtering is called in Indigo Naturalis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103624012A CN102861310B (en) | 2012-09-17 | 2012-09-17 | Medicine for hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103624012A CN102861310B (en) | 2012-09-17 | 2012-09-17 | Medicine for hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102861310A true CN102861310A (en) | 2013-01-09 |
| CN102861310B CN102861310B (en) | 2013-10-09 |
Family
ID=47440625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103624012A Expired - Fee Related CN102861310B (en) | 2012-09-17 | 2012-09-17 | Medicine for hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102861310B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103948906A (en) * | 2014-05-23 | 2014-07-30 | 江苏广达医材集团有限公司 | Traditional Chinese medicine preparation for treating hepatitis B and preparation method thereof |
| CN104491605A (en) * | 2015-01-09 | 2015-04-08 | 王乃伟 | Traditional Chinese medicine composition for treating hepatitis B |
| CN105582331A (en) * | 2015-12-29 | 2016-05-18 | 顾海峰 | Health-care product containing moringa oleifera and preparation method of health-care product |
| CN109498743A (en) * | 2018-12-29 | 2019-03-22 | 大连民族大学 | A kind of Chinese medicine for treating hepatitis B |
| CN109865094A (en) * | 2017-12-05 | 2019-06-11 | 蔡丽丽 | A kind of formula for treating hepatitis B |
| CN113813355A (en) * | 2021-10-28 | 2021-12-21 | 廖忠培 | Pill for treating liver cirrhosis and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1160559A (en) * | 1996-11-30 | 1997-10-01 | 李泽良 | Hepatitis B curing toxin-dissipating pill |
| CN1923269A (en) * | 2006-03-06 | 2007-03-07 | 喻可安 | Medicine for treating hepatitis B |
-
2012
- 2012-09-17 CN CN2012103624012A patent/CN102861310B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1160559A (en) * | 1996-11-30 | 1997-10-01 | 李泽良 | Hepatitis B curing toxin-dissipating pill |
| CN1923269A (en) * | 2006-03-06 | 2007-03-07 | 喻可安 | Medicine for treating hepatitis B |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103948906A (en) * | 2014-05-23 | 2014-07-30 | 江苏广达医材集团有限公司 | Traditional Chinese medicine preparation for treating hepatitis B and preparation method thereof |
| CN104491605A (en) * | 2015-01-09 | 2015-04-08 | 王乃伟 | Traditional Chinese medicine composition for treating hepatitis B |
| CN105582331A (en) * | 2015-12-29 | 2016-05-18 | 顾海峰 | Health-care product containing moringa oleifera and preparation method of health-care product |
| CN109865094A (en) * | 2017-12-05 | 2019-06-11 | 蔡丽丽 | A kind of formula for treating hepatitis B |
| CN109498743A (en) * | 2018-12-29 | 2019-03-22 | 大连民族大学 | A kind of Chinese medicine for treating hepatitis B |
| CN113813355A (en) * | 2021-10-28 | 2021-12-21 | 廖忠培 | Pill for treating liver cirrhosis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102861310B (en) | 2013-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102861310B (en) | Medicine for hepatitis B | |
| CN102988656B (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
| CN103007191A (en) | Chinese medicinal composition for treating jaundice | |
| CN103007189B (en) | Chinese medicinal composition for treating acute pancreatitis | |
| CN101947300B (en) | Traditional Chinese medicinal composition for treating liver diseases, preparation method thereof and use thereof | |
| CN103446544A (en) | Chinese medicine pill for treating liver cirrhosis | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN103861001A (en) | Traditional Chinese medicines for treating epidemic hemorrhagic fever | |
| CN103520657B (en) | Traditional Chinese medicine composition for treating obese fatty liver | |
| CN102961674B (en) | Chinese medicinal composition for treating jaundice | |
| CN102512631B (en) | Chinese medicinal composition for treating jaundice | |
| CN101940758B (en) | Traditional Chinese medicinal composition for treating liver diseases, preparation method thereof and application thereof | |
| CN101264218A (en) | Medicaments assembly for clearing heat and removing dampness, smoothing liver and invigorating spleen and preparation thereof | |
| CN101406681B (en) | Chinese medicinal toxin-expelling decoction for uraemia | |
| CN107753880A (en) | A kind of pharmaceutical composition for treating dysmenorrhoea and preparation method thereof | |
| CN102389541A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102133314B (en) | Chinese medicinal preparation for treating ulcerative colitis | |
| CN104523965A (en) | Nephritis treating traditional Chinese medicine composition | |
| CN105943954A (en) | Traditional Chinese medicine preparation, traditional Chinese medicine capsule for treating icterohepatitis and preparation method thereof | |
| CN103893566A (en) | Giant salamander Chinese herbal medicine compound preparation for treating hepatitis B | |
| CN103349752A (en) | Medicine for treating infectious liver disease | |
| CN103202997B (en) | Traditional Chinese medicine compound prescription for treating liver cirrhosis | |
| CN102772595B (en) | Traditional Chinese composition for treating chronic hepatitis B | |
| CN106109731A (en) | A kind of Chinese medicine composition treating chronic hepatopathy and preparation method thereof | |
| CN103432519B (en) | A kind of Chinese medicine being used for the treatment of chronic hepatitis and cirrhosis, liver splenomegaly |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Yu Kean Document name: payment instructions |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131009 |